Raymond James Financial’s Clorox CLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$66.7M Buy
698,827
+433,618
+164% +$41.6M 0.02% 780
2026
Q1
$27.5M Buy
265,209
+26,648
+11% +$3.02M 0.01% 1253
2025
Q4
$24.1M Buy
238,561
+27,639
+13% +$3M 0.01% 1310
2025
Q3
$26M Sell
210,922
-37,652
-15% -$4.67M 0.01% 1239
2025
Q2
$29.8M Sell
248,574
-21,352
-8% -$2.85M 0.01% 1093
2025
Q1
$39.7M Buy
269,926
+36,352
+16% +$5.55M 0.02% 840
2024
Q4
$37.9M Buy
+233,574
New +$38.2M 0.01% 889

Other funds holding CLX

Raymond James Financial's CLX Position: Q2 2026 in Review

Raymond James Financial increased its Clorox (CLX) stake by 164% in Q2 2026, buying an estimated $41.6M and bringing the position to 698,827 shares worth $66.7M. The position accounts for 0.02% of the portfolio, ranked #780.

Raymond James Financial first reported a position in CLX in Q4 2024 and has held it in 7 quarters since. 1,055 funds tracked by Wall St. Rank hold CLX as of Q2 2026.

  • Raymond James Financial held 698,827 shares of Clorox worth $66.7M as of Q2 2026.
  • Raymond James Financial bought 433,618 Clorox shares in Q2 2026, an estimated $41.6M.
  • Clorox made up 0.02% of Raymond James Financial's portfolio in Q2 2026, its #780 holding.
  • Raymond James Financial first reported a position in Clorox in Q4 2024 and has held it in 7 quarters since.
  • 1,055 funds tracked by Wall St. Rank held Clorox as of Q2 2026.

Based on Raymond James Financial's 13F filing for Q2 2026, filed 14 Aug 2026.